The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already ...
Tags: CGH, SAFIR01, DNA, Gustave Roussy
The European Commission has cleared the expanded use of Genzyme's Thyrogen(thyrotropin alfa)cancer therapy for patients with postoperative thyroid remnant ablation. The new approval allows administration of a reduced dose of radioiodine ...
Tags: European Commission, Genzyme, Thyrogen, cancer therapy